Macrolide Antibiotic
Pregnancy: Compatible — azithromycin safe in pregnancy; used for chlamydia treatment
Azithromycin
Brand names: Zithromax
Adult dose
Dose: Community-acquired pneumonia: 500 mg OD for 3–5 days. STI (chlamydia): 1 g single dose. MAC prophylaxis (HIV): 1.25 g once weekly.
Route: Oral or IV
Frequency: OD (3–5 days typical), or single dose
Max: 500 mg/day
Long tissue half-life (68h) — 3-day course equivalent to 10-day amoxicillin in soft tissue infections. QT prolongation — avoid in patients with known QT prolongation or on QT-prolonging drugs.
Paediatric dose
Dose: 10 mg/kg
Route: Oral
Frequency: Once daily (3-day course)
Max: 500 mg/day
Concentration: 40 mg/ml
BNF for Children: 10 mg/kg OD × 3 days (max 500 mg). Neonatal chlamydial conjunctivitis: 20 mg/kg OD × 3 days. Pertussis: 10 mg/kg OD × 5 days. Avoid <6 weeks (hypertrophic pyloric stenosis risk). Source: BNF for Children 2024
Dose adjustments
Renal
No dose adjustment required
Hepatic
Avoid in severe hepatic impairment — hepatically metabolised and excreted
Paediatric weight-based calculator
BNF for Children: 10 mg/kg OD × 3 days (max 500 mg). Neonatal chlamydial conjunctivitis: 20 mg/kg OD × 3 days. Pertussis: 10 mg/kg OD × 5 days. Avoid <6 weeks (hypertrophic pyloric stenosis risk). Source: BNF for Children 2024
Clinical pearls
- Long tissue half-life: do not give repeated short courses; tissue drug persists for 5–7 days after last dose
- COVID-19: widely used in early pandemic but RECOVERY trial showed NO benefit for COVID-19
- Chlamydia treatment: 1 g single dose (azithromycin) or doxycycline 100 mg BD × 7 days — both effective (BASHH guidelines)
- QTc prolongation: check baseline ECG in at-risk patients before prescribing
Contraindications
- Congenital or acquired QT prolongation
- Hypokalaemia or hypomagnesaemia (QT risk)
- Concurrent QT-prolonging drugs
Side effects
- GI upset (nausea, diarrhoea)
- QT prolongation
- Tinnitus and hearing loss (rare — high doses)
- Cholestatic jaundice (rare)
- Anaphylaxis (rare)
Interactions
- QT-prolonging drugs — additive QT prolongation
- Warfarin — may slightly increase INR
- Antacids (aluminium/magnesium) — reduce azithromycin absorption (separate by 2h)
- Digoxin — increased digoxin levels (P-gp inhibition)
Monitoring
- ECG (QTc) if at risk
- GI tolerability
- Clinical response
- LFTs if prolonged use
Reference: BNFc; BNF; BASHH STI Guidelines; RECOVERY Trial (Horby et al, NEJM 2021). Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- FeverPAIN Score for Strep Throat · Throat
- Jarisch-Herxheimer Reaction Severity Assessment · Treatment Reactions
- PID Severity (CDC Diagnostic Criteria) · Gynaecological Infections
- Gustilo-Anderson Classification (Open Fractures) · Fracture Classification
- DRIP Score for Drug-Resistant Pneumonia · Pneumonia
Drugs
Pathways